Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study

Alberto M. La Rosa, Linda J. Harrison, Babafemi Taiwo, Carole L. Wallis, Lu Zheng, Peter Kim, Nagalingeswaran Kumarasamy, Mina C. Hosseinipour, Bernadette Jarocki, John W. Mellors, Ann C. Collier*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study'. Together they form a unique fingerprint.

Medicine & Life Sciences